In this talk Dr Anne Katrin Schlag will speak about medical cannabis in the UK and its long road from principle to practice.
November 1st 2021 will mark the third ‘anniversary’ of the rescheduling of cannabis as a medicine – yet in practice, patient access to medical cannabis remains challenging. Anne will outline the work Drug Science has done these past three years, starting with a critical review of the issues still existing today, before moving on to our current research, focusing on pediatric epilepsy and the development of our Real World Evidence base, project TWENTY21.
(https://www.drugscience.org.uk/project-twenty21-september-update/).
Dr Anne Katrin Schlag is a Chartered Psychologist and Head of Research at Drug Science. She completed her PhD in Psychology at the London School of Economics and Political Science, before working as Lecturer at King’s College London where she developed her expertise across the spectrum of science and policy making, risk perception, risk management and risk communication. She holds Honorary Fellowships at both Imperial College London and King’s College London.
Within her role at Drug Science (https://www.drugscience.org.uk), she leads the research for the Medical Cannabis Working Group, focusing on controversies surrounding medical cannabis, the improvement of patient access, and the continued development of education and stakeholder communication about medical cannabis. Dr Schlag is currently working on progressing the scientific evidence base of medical cannabis to include Patient-Reported Outcomes, observational studies (such as T21) and the application of Multi-Criteria Decision Analysis to assess the benefits and safety of medical cannabis.
This is an online event hosted via Zoom – Register for FREE via Eventbrite.
Stream
